Sunday, December 22, 2024

Canada’s Politics and Government News Source Since 1989

Sunday, December 22, 2024 | Latest Paper

Liberal-NDP deal promises nothing more than a pharmacare pantomime

It is not clear what is new in this announcement. Pharmacare remains just beyond the next election horizon.

Opinion
BY NAV PERSAUD
March 31, 2022

Opinion | BY NAV PERSAUD | March 31, 2022

FOLLOW THE HILL TIMES:

Want to make sure your whole office has the full Hill Times experience?

We have team plans available for companies, organizations, classes, Parliament Hill offices and more. Fill out this form and find out if your team is eligible for a discount.

More Opinion

Hundreds of billions in ‘contingent liabilities’ loom large over Canada

OpinionBY TOM FLANAGAN

Justin Trudeau no longer has a mandate to govern, and he doesn’t care

OpinionBY JAKE ENWRIGHT

Canada needs a stable democratic partner in South Korea

OpinionBY MIKE DANAGHER

What Canada needs in its next prime minister

OpinionBY JOSEPH INGRAM

Like it or not, the die is cast

OpinionBY MICHAEL HARRIS

Related Stories

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

‘Baby-steps’ pharmacare a test of our humanity and of our political leaders

OpinionBY SUSAN RILEY

Trudeau government not being honest about true costs of national pharmacare

OpinionBY JAKE FUSS, MACKENZIE MOIR

Liberals risk ‘intense criticism’ from Conservatives if pharmacare grows federal deficit, says pollster Bruce Anderson

NewsBY IAN CAMPBELL

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

NewsBY JESSE CNOCKAERT

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

Trudeau’s pharmacare plan would likely reduce drug coverage for millions of Canadians

OpinionBY KRISTINA ACRI

The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.

‘Baby-steps’ pharmacare a test of our humanity and of our political leaders

OpinionBY SUSAN RILEY

If the proposals survive, this national pharmacare intro-package should fill open gaps for many insulin-dependent diabetics, especially those with Type 1 diabetes. But there is scant hope of a full-fledged pharmacare program anytime soon.

‘Baby-steps’ pharmacare a test of our humanity and of our political leaders

OpinionBY SUSAN RILEY

If the proposals survive, this national pharmacare intro-package should fill open gaps for many insulin-dependent diabetics, especially those with Type 1 diabetes. But there is scant hope of a full-fledged pharmacare program anytime soon.

Trudeau government not being honest about true costs of national pharmacare

OpinionBY JAKE FUSS, MACKENZIE MOIR

The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the future. And yet, pharmacare is being presented to Canadians as if there’s no direct cost to them.

Trudeau government not being honest about true costs of national pharmacare

OpinionBY JAKE FUSS, MACKENZIE MOIR

The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the future. And yet, pharmacare is being presented to Canadians as if there’s no direct cost to them.

Liberals risk ‘intense criticism’ from Conservatives if pharmacare grows federal deficit, says pollster Bruce Anderson

NewsBY IAN CAMPBELL

Recent reports from the Parliamentary Budget Office found that a universal pharmacare program could cost both provincial and federal governments $11.2-billion in its first year, while the federal deficit is already projected to grow to $46.5-billion next year.

Liberals risk ‘intense criticism’ from Conservatives if pharmacare grows federal deficit, says pollster Bruce Anderson

NewsBY IAN CAMPBELL

Recent reports from the Parliamentary Budget Office found that a universal pharmacare program could cost both provincial and federal governments $11.2-billion in its first year, while the federal deficit is already projected to grow to $46.5-billion next year.